Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$3.76 - $6.02 $31,929 - $51,121
8,492 Added 17.94%
55,832 $266,000
Q4 2023

Feb 13, 2024

BUY
$4.8 - $7.67 $18,652 - $29,805
3,886 Added 8.94%
47,340 $227,000
Q3 2023

Nov 13, 2023

BUY
$6.81 - $9.74 $10,521 - $15,048
1,545 Added 3.69%
43,454 $314,000
Q2 2023

Aug 04, 2023

BUY
$6.67 - $9.52 $271,015 - $386,816
40,632 Added 3181.83%
41,909 $311,000
Q1 2023

May 12, 2023

BUY
$5.76 - $12.48 $472 - $1,023
82 Added 6.86%
1,277 $8,000
Q4 2022

Feb 10, 2023

SELL
$8.86 - $25.04 $239 - $676
-27 Reduced 2.21%
1,195 $12,000
Q3 2022

Nov 14, 2022

BUY
$18.2 - $76.12 $72 - $304
4 Added 0.33%
1,222 $22,000
Q2 2022

Aug 12, 2022

SELL
$36.28 - $75.29 $7,727 - $16,036
-213 Reduced 14.88%
1,218 $63,000
Q4 2021

Feb 11, 2022

SELL
$134.56 - $217.97 $2,556 - $4,141
-19 Reduced 1.31%
1,431 $205,000
Q3 2021

Nov 12, 2021

SELL
$177.8 - $270.58 $19,735 - $30,034
-111 Reduced 7.11%
1,450 $301,000
Q2 2021

Aug 13, 2021

SELL
$121.0 - $257.67 $4.32 Million - $9.2 Million
-35,695 Reduced 95.81%
1,561 $331,000
Q1 2021

May 07, 2021

SELL
$112.98 - $319.93 $9,264 - $26,234
-82 Reduced 0.22%
37,256 $6.76 Million
Q4 2020

Feb 12, 2021

BUY
$78.74 - $139.5 $37,637 - $66,681
478 Added 1.3%
37,338 $4.16 Million
Q3 2020

Nov 04, 2020

BUY
$79.44 - $178.51 $96,519 - $216,889
1,215 Added 3.41%
36,860 $3.99 Million
Q2 2020

Aug 12, 2020

BUY
$13.86 - $83.61 $230,533 - $1.39 Million
16,633 Added 87.49%
35,645 $2.97 Million
Q1 2020

May 04, 2020

BUY
$3.93 - $16.0 $9,329 - $37,984
2,374 Added 14.27%
19,012 $258,000
Q4 2019

Feb 05, 2020

BUY
$3.69 - $5.22 $5,664 - $8,012
1,535 Added 10.16%
16,638 $66,000
Q3 2019

Nov 08, 2019

BUY
$4.02 - $7.84 $731 - $1,426
182 Added 1.22%
15,103 $76,000
Q2 2019

Aug 13, 2019

BUY
$4.93 - $12.2 $73,560 - $182,036
14,921 New
14,921 $87,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $680M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.